Palatin Technologies
PTN
#9830
Rank
C$63.85 M
Marketcap
C$37.51
Share price
10.46%
Change (1 day)
3,076.39%
Change (1 year)

Market capitalization of Palatin Technologies (PTN)

Market cap: C$63.85 Million

As of December 2025 Palatin Technologies has a market cap of C$63.85 Million. This makes Palatin Technologies the world's 9830th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Palatin Technologies from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025C$63.85 M70.92%
2024C$37.36 M-48.48%
2023C$72.51 M101.62%
2022C$35.96 M-76.16%
2021C$0.15 B-23.9%
2020C$0.19 B-15.34%
2019C$0.23 B19.48%
2018C$0.19 B-4.65%
2017C$0.20 B126.92%
2016C$90.56 M44.53%
2015C$62.66 M78.07%
2014C$35.19 M14.92%
2013C$30.62 M31.8%
2012C$23.23 M62.84%
2011C$14.26 M-10.81%
2010C$15.99 M-57.24%
2009C$37.4 M294.88%
2008C$9.47 M-44.28%
2007C$16.99 M-89.94%
2006C$0.16 B-24.59%
2005C$0.22 B29.9%
2004C$0.17 B17.2%
2003C$0.14 B66.11%
2002C$88.65 M-17.74%
2001C$0.10 B96.13%
2000C$54.94 M107.49%
1999C$26.48 M-18.52%
1998C$32.49 M26.43%
1997C$25.7 M643.38%
1996C$3.45 M

End of Day market cap according to different sources

On Dec 14th, 2025 the market cap of Palatin Technologies was reported to be:

C$63.85 Million
by Nasdaq info icon info icon
C$63.85 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MediciNova
MNOV
C$0.10 B 63.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
C$13.94 M-78.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$20.96 B 32,733.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$2.48 B 3,791.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$5.13 B 7,940.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
C$4.09 B 6,317.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$701.60 B 1,098,567.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$2.07 B 3,152.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$383.34 B 600,194.38%๐Ÿ‡ฌ๐Ÿ‡ง UK